No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
|
This complaint is from a literature source.The following literature cite has been reviewed: karkowski g, kuniewicz m, kozluk e, chyzy t, zabek a, dusza m, lelakowski j.Non-fluoroscopic radiofrequency catheter ablation of right- and left-sided ventricular arrhythmias.Postepy kardiol interwencyjnej.2020 sep;16(3):321-329.Doi: 10.5114/aic.2020.99268.Epub 2020 oct 2.Pmid: 33597998; pmcid: pmc7863801.Objective/methods/study data: this study includes 128 patients who underwent radiofrequency catheter ablation of ventricular arrhythmias from 2014 to 2018.Patients were divided into two groups: non-fluoroscopic - radiofrequency catheter ablation and fluoroscopic- radiofrequency catheter ablation.Patients in each group were then subsequently subdivided into two groups based on ventricular arrhythmias localization ¿ left- (ls-va) and right-sided (rs-va) ventricular arrhythmias.The aim of this study was the analysis of safety and effectiveness of non-fluoroscopic- radiofrequency catheter ablation of ventricular arrhythmias from left- and right-sided cardiac chambers.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: smarttouch.Concomitant other biosense webster devices that were also used in this study: carto.Concomitant non-biosense webster devices that were also used in this study: n/a.Adverse event(s) and provided interventions: there were 4 (4.6%) perioperative complications in non-fluoroscopic - radiofrequency catheter ablation.Qty 1: pseudoaneurysm after femoral artery access, treated by thrombin injection.Qty 1: first degree of atrioventricular block after ectopic ventricular ablation.Qty 1: pericarditis after ablation, that required pharmacotherapy.Qty 1: pericarditis after ablation, that required pericardiocentesis because of the symptomatic pericardial effusion.
|